Targeting c-Myc: JQ1 as a promising option for c-Myc-amplified esophageal squamous cell carcinoma

Wang, JY; Liu, ZT; Wang, ZQ; Wang, SB; Chen, ZH; Li, ZW; Zhang, MQ; Zou, JL; Dong, B; Gao, J; Shen, L

Gao, J; Shen, L (reprint author), Fu Cheng Rd 52, Beijing 100142, Peoples R China.

CANCER LETTERS, 2018; 419 (): 64

Abstract

c-Myc amplification-induced cell cycle dysregulation is a common cause for esophageal squamous cell carcinoma (ESCC), but no approved targeted drug is......

Full Text Link